EP3177321

TUMOR ANTIGEN SPECIFIC ANTIBODIES AND TLR3 STIMULATION TO ENHANCE THE PERFORMANCE OF CHECKPOINT INTERFERENCE THERAPY OF CANCER

  • :
    EP einkaleyfi: Þýðing ekki lögð inn
  • :
    7.8.2015
  • :
    25.11.2020
  • :
    15829910.7
  • :
    6.8.2035
  • :
    TUMOR ANTIGEN SPECIFIC ANTIBODIES AND TLR3 STIMULATION TO ENHANCE THE PERFORMANCE OF CHECKPOINT INTERFERENCE THERAPY OF CANCER

7.8.2015
25.11.2020
  • :
    Oncoquest Pharmaceuticals Inc.
  • :
    670-21 Sannae-ro, Sannae-myeon, Miryang-Si, KR
  • :
    MADIYALAKAN, Ragupathy
  • :
    Edmonton, Alberta T6E 2S1, CA
  • :
    NICODEMUS, Christopher F.
  • :
    Charlestown, Massachusetts 02129, US
  • :
    201462034915 P
  • :
    8.8.2014
  • :
    US
  • :
    CA2015050747
  • :
    7.8.2015
  • :
    A61K 39/395, A61K 39/39, A61P 35/00, A61P 37/02